NDC 54925-063 - Atropine Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54925-063
- Package NDCs from labels
- 54925-063-10
- Manufacturer
- Med-Pharmex, Inc
- Effective date
- 2008-04-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Atropine Sulfate - Med-Pharmex, Inc | Med-Pharmex, Inc | 2008-04-01 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ATROPINE SULFATE | ACTIVE INGREDIENT | 03J5ZE7KA5 | ATROPINE SULFATE INJECTION, SOLUTION [MED-PHARMEX, INC] | 1 | |
| ATROPINE | ACTIVE MOIETY | 7C0697DR9I | ATROPINE SULFATE INJECTION, SOLUTION [MED-PHARMEX, INC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atropine Sulfate | ATROPINE SULFATE MONOHYDRATE | Somerset Therapeutics, LLC | 84ba1689-3030-48d5-9cce-70b5a24a4033 | 2024-12-10 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Donnatal | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | Advanz Pharma (US) Corp. | c93cccdc-2f92-4cb3-9d14-06acdd51d94c | 2024-12-05 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Donnatal | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | Advanz Pharma (US) Corp. | 4dba30db-7979-455f-a225-24f0a04d744e | 2024-12-05 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | Accord Healthcare Inc. | f3cb74e9-b4ac-4efe-bd8e-8a71970ee7c7 | 2024-11-20 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | A-S Medication Solutions | 1be4dd7d-766c-4b3c-8b86-4f219ab44726 | 2024-11-13 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | Fresenius Kabi USA, LLC | 310c8a74-ea24-4357-8099-81e394b1634e | 2024-10-11 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| STOMAPLEX | CARDUUS MARIANUS, GENTIANA LUTEA, SAMBUCUS NIGRA, SENNA (CASSIA ANGUSTIFOLIA), STOMACH (BOVINE), ARSENICUM ALBUM, ATROPINUM SULPHURICUM, CARBO VEGETABILIS, LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORUS | BioActive Nutritional, Inc. | e1b69e9b-ab47-49f4-bd91-89c935533d67 | 2024-09-11 | Warnings | 03J5ZE7KA5 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Bryant Ranch Prepack | b3f58de9-1cc8-4bc5-842f-010cc48d3582 | 2024-08-23 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | NuCare Pharmaceuticals,Inc. | 575c38b4-7ec0-6d25-e053-2a91aa0a80fc | 2024-07-18 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | Somerset Therapeutics, LLC | a6fac578-c7bc-4b3c-a454-7889cc819118 | 2024-07-04 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE MONOHYDRATE | Somerset Therapeutics, LLC | bfdb85b2-86d0-4f32-a8fa-272af48a191c | 2024-05-24 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Aphena Pharma Solutions - Tennessee, LLC | 14bf7191-580f-76dc-e063-6294a90aed2a | 2024-04-08 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| ATROPINE SULFATE | ATROPINE SULFATE | HF Acquisition Co. LLC, DBA Health First | 74106ef7-83bf-47ba-e053-2991aa0aaec1 | 2024-03-08 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| ATROPINE SULFATE | ATROPINE SULFATE | HF Acquisition Co LLC, DBA HealthFirst | 0060b971-19bd-2849-e063-6294a90afca8 | 2024-01-28 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| ATROPINE SULFATE | ATROPINE SULFATE | HF Acquisition Co LLC, DBA HealthFirst | e9fd624a-9abd-dfea-e053-2a95a90a8e9d | 2024-01-28 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| ATROPINE SULFATE | ATROPINE SULFATE | HF Acquisition Co., LLC, DBA Health First | 73de9878-a08a-4966-e053-2a91aa0ab0f6 | 2024-01-25 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine sulfate | ATROPINE SULFATE | HF Acquisition Co LLC, DBA HealthFirst | 007728fc-f4cb-d519-e063-6394a90ae033 | 2024-01-22 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| ATROPINE SULFATE | ATROPINE SULFATE | HF Acquisition Co LLC, DBA HealthFirst | c0d0ca2a-4267-41b7-e053-2a95a90a4726 | 2024-01-22 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| A09 FEMALE BALANCE | ARGENTUM NITRICUM, ATROPINUM SULPHURICUM, AURUM MURIATICUM NATRONATUM, BOS TAURUS OVARY, BOS TAURUS PANCREAS, BOS TAURUS PITUITARUM POSTERIUM, BOS TAURUS UTERUS, CIMICIFUGA RACEMOSA, ESTRONE, HELONIAS DIOICA, PROGESTERONE, PULSATILLA VULGARIS, SABINA, SEPIA, SEQUOIADENDRON GIGANTEUM WHOLE, SUS SCROFA PINEAL GLAND, SUS SCROFA SPLEEN, THIOSINAMINUM, THYROIDINUM, VIBURNUM OPULUS | Apex Energetics Inc. | b8e1ba2a-f80f-158e-e053-2a95a90aacd1 | 2024-01-08 | Warnings | 03J5ZE7KA5 |
| Atropine | ATROPINE SULFATE | A-S Medication Solutions | 1b2d030e-c0ec-484b-a228-76011702cdd0 | 2024-01-02 | Warnings, Adverse reactions | 03J5ZE7KA5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.